Latest Breaking News On - Pooya hemami - Page 7 : comparemela.com

Nicox: 2022 Extraordinary Shareholder Meeting

Press ReleaseNicox: 2022 Extraordinary Shareholder MeetingJuly 8, 2022 - release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company

France generalUnited kingdomGavin spencerKepler cheuvreux arsene guekamPharma bioStates europeValbonne sophia antipolisSophia antipolisHead of corporate developmentLifesci advisorsCompany investor relationsEyevance pharmaceuticalsEdison investment research pooya hemami londonGarnier co dylan van haaften parisEuronext parisMonday july

Nicox Announces Publication of NCX 470 Results Demonstrating Improvements to Ocular Hemodynamics and Retinal Cell Physiology

Press Release Nicox Announces Publication of NCX 470 Results Demonstrating Improvements to Ocular Hemodynamics and Retinal Cell PhysiologyJuly 7, 2022 - release at 7:30 am CET Sophia Antipolis, FranceNicox

United statesProvence alpes côd azurFrance generalUnited kingdomGavin spencerDoug hubatschKepler cheuvreux arsene guekamPharma bioStates europeMont blancSophia antipolisHead of corporate developmentLifesci advisorsEyevance pharmaceuticalsAbbvie incEdison investment research pooya hemami london

Nicox Accelerates Topline Results from NCX 470 Mont Blanc Phase 3 Glaucoma Trial to November 2022

Nicox Accelerates Topline Results from NCX 470 Mont Blanc Phase 3 Glaucoma Trial to November 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrance generalCity ofUnited kingdomYi chenPharma bioArsene guekamPooya hemamiStateskepler cheuvreuxMont blancSophia antipolisDylan van haaftenAndreas segerrosFranceedison investment researchUkhc wainwright co

Nicox: 2022 Extraordinary Shareholder Meeting

Press ReleaseNicox: 2022 Extraordinary Shareholder MeetingJune 3, 2022 - release at 8:30 am CETSophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company

France generalUnited kingdomGavin spencerKepler cheuvreux arsene guekamPharma bioStates europeValbonne sophia antipolisSophia antipolisHead of corporate developmentLifesci advisorsCompany investor relationsEyevance pharmaceuticalsEdison investment research pooya hemami londonGarnier co dylan van haaften parisEuronext parisMonday july

Nicox (COX): Eye health portfolio targets large markets

Edison Investment Research Limited Nicox (COX): Eye health portfolio targets large markets 23-May-2022 / 07:00 GMT/BST   London.

New yorkUnited statesNew south walesUnited kingdomTel avivSouth africaCity ofNoord hollandMont blancPooya hemamiFinancial conduct authorityMont blanc phaseFinancial conduct